Skip to main content
. 2021 Aug 3;13(1):54–64. doi: 10.1111/jdi.13624

Figure 4.

Figure 4

Effects of canagliflozin on safety outcomes in participants in East and South‐East Asian and non‐East and South‐East Asian countries in Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE). Cana, canagliflozin; CI, confidence interval; EA, East and South‐East Asia; non‐EA, non‐East and South‐East Asia.